MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Cholinergic Brain Signature of Presbyvestibulopathy in Parkinson’s Disease: Exploring Central Nervous System Vestibular Mechanisms

P. Kanel, G. Carli, T. Brown, S. David, R. Vangel, C. Pongmala, D. Mccaslin, K. Kerber, N. Bohnen (Ann Arbor, USA)

Meeting: 2024 International Congress

Abstract Number: 119

Keywords: Acetylcholine, Parkinson’s

Category: Parkinson's Disease and Lewy Body Dementia

Objective: To investigate topographic cholinergic brain differences between Parkinson’s disease (PD) patients with and without presbyvestibulopathy (PVP).

Background: Age-associated vestibulopathy (PVP) is commonly observed in both neurologically intact older adults and age-associated disorders like PD. As individuals age, the vestibular system naturally undergoes a vestibular function frequency-dependent decline. However, those with PD may experience more pronounced dysfunction in this system because of post-mortem evidence of alpha-synuclein deposition in vestibular brainstem nuclei and connected regions. Therefore, the presence of inherent PD-related vestibular changes could potentially exacerbate the effects of age-associated vestibulopathy. A promising candidate for central nervous system involvement in PVP in PD might be the cholinergic system, given the role of anti-cholinergic drugs in treating peripheral vestibular hyperfunctions, such as vertigo. However, less is known of cholinergic system changes associated with vestibular hypofunction, such as seen in PVP.

Method: 25 participants with PD (13 Males, 12 Females, Age: 68.96±5.2, UPDRS-III: 43.24±16.00). 10 PD patients (40%) were classified with PVP according to Barany Society criteria using multifrequency vestibular testing [1]. All patients underwent a Fluorine-18-fluoroethoxybenzovesamicol ([18F]FEOBV) vesicular acetylcholine transporter brain PET. We performed a whole brain voxel-wise group comparison between PD patients with PVP and those without PVP. The threshold was set at p<0.01, K>50.

Results: PD patients with PVP exhibited reduced cholinergic activity compared to PD patients without PVP, particularly in an occipito-parietal cluster lateralized to the left hemisphere. Specifically, this cluster included the left lingual gyrus, left optic radiation, calcarine cortex, left middle occipital gyrus, left angular gyrus, and midbrain [figure1].

Conclusion: These findings suggest that presbyvestibulopathy in PD involves the cholinergic central nervous system and specifically affects posterior brain cholinergic innervation. This may explain at least in part the previously shown association between the cholinergic system and gait and balance impairments in PD.

Figure 1

Figure 1

References: [1] Agrawal, Y., Van de Berg, R., Wuyts, F., Walther, L., Magnusson, M., Oh, E., Sharpe, M., Strupp,.M. (2019). Presbyvestibulopathy: Diagnostic criteria Consensus document of the classification committee of the Bárány Society. Journal of Vestibular Research, 29(4), 161-170

To cite this abstract in AMA style:

P. Kanel, G. Carli, T. Brown, S. David, R. Vangel, C. Pongmala, D. Mccaslin, K. Kerber, N. Bohnen. Cholinergic Brain Signature of Presbyvestibulopathy in Parkinson’s Disease: Exploring Central Nervous System Vestibular Mechanisms [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/cholinergic-brain-signature-of-presbyvestibulopathy-in-parkinsons-disease-exploring-central-nervous-system-vestibular-mechanisms/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/cholinergic-brain-signature-of-presbyvestibulopathy-in-parkinsons-disease-exploring-central-nervous-system-vestibular-mechanisms/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley